Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1276

1.

Invasive non-native species likely to threaten biodiversity and ecosystems in the Antarctic Peninsula region.

Hughes KA, Pescott OL, Peyton J, Adriaens T, Cottier-Cook EJ, Key G, Rabitsch W, Tricarico E, Barnes DKA, Baxter N, Belchier M, Blake D, Convey P, Dawson W, Frohlich D, Gardiner LM, González-Moreno P, James R, Malumphy C, Martin S, Martinou AF, Minchin D, Monaco A, Moore N, Morley SA, Ross K, Shanklin J, Turvey K, Vaughan D, Vaux AGC, Werenkraut V, Winfield IJ, Roy HE.

Glob Chang Biol. 2020 Jan 13. doi: 10.1111/gcb.14938. [Epub ahead of print]

PMID:
31930639
2.

Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update.

Moore N.

Drug Saf. 2020 Jan 8. doi: 10.1007/s40264-019-00900-8. [Epub ahead of print] Review.

PMID:
31916080
3.

Medications for Treating Infection.

Grennan D, Varughese C, Moore NM.

JAMA. 2020 Jan 7;323(1):100. doi: 10.1001/jama.2019.17387. No abstract available.

PMID:
31910281
4.

Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma.

Nassar AH, Abou Alaiwi S, AlDubayan SH, Moore N, Mouw KW, Kwiatkowski DJ, Choueiri TK, Curran C, Berchuck JE, Harshman LC, Nuzzo PV, Chanza NM, Van Allen E, Esplin ED, Yang S, Callis T, Garber JE, Rana HQ, Sonpavde G.

Genet Med. 2019 Dec 17. doi: 10.1038/s41436-019-0720-x. [Epub ahead of print]

PMID:
31844177
5.

Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.

Moore NL, Hanson AR, Ebrahimie E, Hickey TE, Tilley WD.

J Steroid Biochem Mol Biol. 2019 Dec 2;199:105548. doi: 10.1016/j.jsbmb.2019.105548. [Epub ahead of print]

PMID:
31805393
6.

Seeing red degeneration in uterine fibroids in pregnancy: proceed with caution.

Cerdeira AS, Tome M, Moore N, Lim L.

Lancet. 2019 Nov 23;394(10212):e37. doi: 10.1016/S0140-6736(19)32322-0. No abstract available.

PMID:
31777390
7.

Pharmacoepidemiology.

Moore N, Blin P, Droz C.

Handb Exp Pharmacol. 2019;260:433-451. doi: 10.1007/164_2019_318. Review.

PMID:
31768750
8.

The application of Strategy-based Training to Enhance Memory (STEM) in multiple sclerosis: A pilot RCT.

Chiaravalloti ND, Moore NB, Weber E, DeLuca J.

Neuropsychol Rehabil. 2019 Nov 21:1-24. doi: 10.1080/09602011.2019.1685550. [Epub ahead of print]

PMID:
31752604
9.

Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort.

Rouyer M, Oudard S, Joly F, Fizazi K, Tubach F, Jove J, Lacueille C, Lamarque S, Guiard E, Balestra A, Droz-Perroteau C, Fourrier-Reglat A, Moore N; FUJI Investigators.

Br J Cancer. 2019 Dec;121(12):1001-1008. doi: 10.1038/s41416-019-0611-6. Epub 2019 Nov 13.

10.

Doctors' perspectives on adhering to advance care directives when making medical decisions for patients: an Australian interview study.

Moore N, Detering KM, Low T, Nolte L, Fraser S, Sellars M.

BMJ Open. 2019 Oct 31;9(10):e032638. doi: 10.1136/bmjopen-2019-032638.

11.

A Microfluidic Device to Enhance Viral Transduction Efficiency During Manufacture of Engineered Cellular Therapies.

Moore N, Chevillet JR, Healey LJ, McBrine C, Doty D, Santos J, Teece B, Truslow J, Mott V, Hsi P, Tandon V, Borenstein JT, Balestrini J, Kotz K.

Sci Rep. 2019 Oct 22;9(1):15101. doi: 10.1038/s41598-019-50981-9.

12.

Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study.

Fauchier L, Blin P, Sacher F, Dureau-Pournin C, Bernard MA, Lassalle R, Droz-Perroteau C, Dallongeville J, Moore N.

Europace. 2019 Oct 22. pii: euz285. doi: 10.1093/europace/euz285. [Epub ahead of print]

PMID:
31638652
13.

Pharmacological treatment patterns in heart failure: a population-based cohort study.

Bosco-Lévy P, Favary C, Jové J, Lassalle R, Moore N, Droz-Perroteau C.

Eur J Clin Pharmacol. 2020 Jan;76(1):97-106. doi: 10.1007/s00228-019-02758-2. Epub 2019 Oct 21.

PMID:
31637454
14.

Pharmacovigilance - The next chapter.

Moore N, Berdaï D, Blin P, Droz C.

Therapie. 2019 Dec;74(6):557-567. doi: 10.1016/j.therap.2019.09.004. Epub 2019 Oct 1.

PMID:
31623850
15.

Mycobacterium Spindle Cell Pseudotumor Caused by Mycobacterium xenopi: A First Described Association of a Rare Entity Presenting in the Lung.

Furlan K, Rohra P, Mir F, Sethi S, Almajnooni A, Gattuso P, Moore N.

Int J Surg Pathol. 2019 Oct 10:1066896919879745. doi: 10.1177/1066896919879745. [Epub ahead of print]

PMID:
31601138
16.

The Reply.

Bezin J, Moore N, Steg PG, Pariente A.

Am J Med. 2019 Jul;132(7):e622. doi: 10.1016/j.amjmed.2019.03.004. No abstract available.

PMID:
31400794
17.

Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation.

Blin P, Fauchier L, Dureau-Pournin C, Sacher F, Dallongeville J, Bernard MA, Lassalle R, Droz-Perroteau C, Moore N.

Stroke. 2019 Sep;50(9):2469-2476. doi: 10.1161/STROKEAHA.119.025824. Epub 2019 Aug 8.

18.

Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization study.

Ibáñez L, Sabaté M, Vidal X, Ballarin E, Rottenkolber M, Schmiedl S, Heeke A, Huerta C, Martin Merino E, Montero D, Leon-Muñoz LM, Gasse C, Moore N, Droz C, Lassalle R, Aakjaer M, Andersen M, De Bruin ML, Groenwold R, van den Ham HA, Souverein P, Klungel O, Gardarsdottir H.

Br J Clin Pharmacol. 2019 Nov;85(11):2524-2539. doi: 10.1111/bcp.14071. Epub 2019 Sep 4.

19.

A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction.

Takebe N, Beumer JH, Kummar S, Kiesel BF, Dowlati A, O'Sullivan Coyne G, Piekarz R, Rubinstein L, Fogli LK, Vaishampayan U, Goel S, O'Bryant CL, El-Rayes BF, Chung V, Lenz HJ, Kim R, Belani CP, Tuscano JM, Schelman W, Moore N, Doroshow JH, Chen AP.

Br J Clin Pharmacol. 2019 Nov;85(11):2499-2511. doi: 10.1111/bcp.14054. Epub 2019 Sep 4.

20.

Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS.

Blin P, Dureau-Pournin C, Bénichou J, Cottin Y, Mismetti P, Abouelfath A, Lassalle R, Droz C, Moore N.

Am J Cardiovasc Drugs. 2020 Feb;20(1):81-103. doi: 10.1007/s40256-019-00359-z.

PMID:
31254174
21.

Full-scale comparison of UV/H2O2 and UV/Cl2 advanced oxidation: The degradation of micropollutant surrogates and the formation of disinfection byproducts.

Wang C, Moore N, Bircher K, Andrews S, Hofmann R.

Water Res. 2019 Sep 15;161:448-458. doi: 10.1016/j.watres.2019.06.033. Epub 2019 Jun 13.

PMID:
31228664
22.

Interstitial lung disease in patients with common variable immunodeficiency disorders: several different pathologies?

Patel S, Anzilotti C, Lucas M, Moore N, Chapel H.

Clin Exp Immunol. 2019 Nov;198(2):212-223. doi: 10.1111/cei.13343. Epub 2019 Jul 10.

PMID:
31216049
23.

The functional observational battery and modified Irwin test as global neurobehavioral assessments in the rat: Pharmacological validation data and a comparison of methods.

Redfern WS, Dymond A, Strang I, Storey S, Grant C, Marks L, Barnard C, Heys C, Moyser K, Greenwood K, Cobey D, Moore N, Karp NA, Prior H.

J Pharmacol Toxicol Methods. 2019 Jul - Aug;98:106591. doi: 10.1016/j.vascn.2019.106591. Epub 2019 May 27.

PMID:
31146025
24.

Posterior Approach to Meckel's Cave: Retrosigmoid Craniectomy with Endoscopic Assistance.

Das P, Borghei-Razavi H, Moore NZ, Recinos PF.

J Neurol Surg B Skull Base. 2019 Jun;80(Suppl 3):S331-S332. doi: 10.1055/s-0039-1677851. Epub 2019 Mar 4.

25.

Scalable high-throughput acoustophoresis in arrayed plastic microchannels.

Dubay R, Lissandrello C, Swierk P, Moore N, Doty D, Fiering J.

Biomicrofluidics. 2019 May 9;13(3):034105. doi: 10.1063/1.5096190. eCollection 2019 May.

PMID:
31123537
26.

Characteristics and Clinical Outcomes of Patients With Spontaneous Coronary Artery Dissection.

Clare R, Duan L, Phan D, Moore N, Jorgensen M, Ichiuji A, Shen AY, Lee MS.

J Am Heart Assoc. 2019 May 21;8(10):e012570. doi: 10.1161/JAHA.119.012570.

27.

Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study.

Guiard E, Lelievre B, Rouyer M, Zerbib F, Diquet B, Mégraud F, Tison F, Bignon E, Lassalle R, Droz-Perroteau C, Moore N, Blin P.

Drug Saf. 2019 Aug;42(8):993-1003. doi: 10.1007/s40264-019-00821-6.

PMID:
31069703
28.

Hypermobility, developmental coordination disorder and physical activity in an Irish paediatric population.

Moore N, Rand S, Simmonds J.

Musculoskeletal Care. 2019 Jun;17(2):261-269. doi: 10.1002/msc.1392. Epub 2019 May 6.

PMID:
31062457
29.

Randomised controlled trial of simulation-based education for mechanical cardiopulmonary resuscitation training.

Coggins AR, Nottingham C, Byth K, Ho KR, Aulia FA, Murphy M, Shetty AL, Todd A, Moore N.

Emerg Med J. 2019 May;36(5):266-272. doi: 10.1136/emermed-2017-207431.

PMID:
31015214
30.

A prospective evaluation of the 'C.O.A.C.H.E.D.' cognitive aid for emergency defibrillation.

Coggins A, Nottingham C, Chin M, Warburton S, Han M, Murphy M, Sutherland J, Moore N.

Australas Emerg Care. 2018 Aug;21(3):81-86. doi: 10.1016/j.auec.2018.08.002. Epub 2018 Sep 10.

PMID:
30998882
31.

Early post-Humanitarian Device Exemption experience with the Neuroform Atlas stent.

Tsai JP, Hardman J, Moore NZ, Hussain MS, Bain MD, Rasmussen PA, Masaryk TJ, Elgabaly MH, Sheikhi L, Toth G.

J Neurointerv Surg. 2019 Nov;11(11):1141-1144. doi: 10.1136/neurintsurg-2019-014874. Epub 2019 Apr 12.

PMID:
30979847
32.

A review of Algerian medicinal plants used in the treatment of diabetes.

Hamza N, Berke B, Umar A, Cheze C, Gin H, Moore N.

J Ethnopharmacol. 2019 Jun 28;238:111841. doi: 10.1016/j.jep.2019.111841. Epub 2019 Apr 5.

PMID:
30959140
33.

Far lateral approach for microsurgical ligation of C1 dural arteriovenous fistula: surgical anatomy and technical nuances.

Kshettry VR, Moore NZ, Bain M.

Neurosurg Focus. 2019 Apr 1;46(Suppl_2):V6. doi: 10.3171/2019.2.FocusVid.18697.

PMID:
30939435
34.

Antarctic Penguins as Reservoirs of Diversity for Avian Avulaviruses.

Wille M, Aban M, Wang J, Moore N, Shan S, Marshall J, González-Acuña D, Vijaykrishna D, Butler J, Wang J, Hall RJ, Williams DT, Hurt AC.

J Virol. 2019 May 15;93(11). pii: e00271-19. doi: 10.1128/JVI.00271-19. Print 2019 Jun 1.

35.

Six-year survival study after myocardial infarction: The EOLE prospective cohort study. Long-term survival after MI.

Droz-Perroteau C, Blin P, Dureau-Pournin C, Thomas D, Danchin N, Tricoire J, Paillard F, Hercberg S, Guize L, Guiard E, Maïzi H, Bernard MA, Bénichou J, Moore N.

Therapie. 2019 Sep;74(4):459-468. doi: 10.1016/j.therap.2019.02.001. Epub 2019 Feb 25.

PMID:
30878144
36.

Prevalence of pathogenic and likely pathogenic variants in the RASopathy genes in patients who have had panel testing for cardiomyopathy.

Aljeaid D, Sanchez AI, Wakefield E, Chadwell SE, Moore N, Prada CE, Zhang W.

Am J Med Genet A. 2019 Apr;179(4):608-614. doi: 10.1002/ajmg.a.61072. Epub 2019 Feb 14.

PMID:
30762279
37.

The efficacy of the modified Story Memory Technique in progressive MS.

Chiaravalloti ND, Moore NB, DeLuca J.

Mult Scler. 2019 Feb 11:1352458519826463. doi: 10.1177/1352458519826463. [Epub ahead of print]

PMID:
30741103
38.

Confidence in Women's Health: A Cross Border Survey of Adult Nephrologists.

Hendren EM, Reynolds ML, Mariani LH, Zee J, O'Shaughnessy MM, Oliverio AL, Moore NW, Hill-Callahan P, Rizk DV, Almanni S, Twombley KE, Herreshoff E, Nester CM, Hladunewich MA.

J Clin Med. 2019 Feb 3;8(2). pii: E176. doi: 10.3390/jcm8020176.

39.

Pharmacoepidemiology of statins.

Bezin J, Moore N.

Therapie. 2019 Apr;74(2):261-269. doi: 10.1016/j.therap.2019.01.004. Epub 2019 Jan 18.

PMID:
30704765
40.

Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors.

AlDubayan SH, Pyle LC, Gamulin M, Kulis T, Moore ND, Taylor-Weiner A, Hamid AA, Reardon B, Wubbenhorst B, Godse R, Vaughn DJ, Jacobs LA, Meien S, Grgic M, Kastelan Z, Markt SC, Damrauer SM, Rader DJ, Kember RL, Loud JT, Kanetsky PA, Greene MH, Sweeney CJ, Kubisch C, Nathanson KL, Van Allen EM, Stewart DR, Lessel D; Regeneron Genetics Center (RGC) Research Team.

JAMA Oncol. 2019 Apr 1;5(4):514-522. doi: 10.1001/jamaoncol.2018.6477.

41.

Real-Life Benefits of Statins for Cardiovascular Prevention in Elderly Subjects: A Population-Based Cohort Study.

Bezin J, Moore N, Mansiaux Y, Steg PG, Pariente A.

Am J Med. 2019 Jun;132(6):740-748.e7. doi: 10.1016/j.amjmed.2018.12.032. Epub 2019 Jan 18.

PMID:
30660573
42.

Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database.

Blin P, Dureau-Pournin C, Benichou J, Bonello L, Dallongeville J, Danchin N, Falissard B, Thomas-Delecourt F, Jové J, Lassalle R, Droz C, Moore N.

Atherosclerosis. 2019 Feb;281:98-106. doi: 10.1016/j.atherosclerosis.2018.11.037. Epub 2018 Dec 7.

PMID:
30658197
43.

Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort study.

Blin P, Samama CM, Sautet A, Benichou J, Lignot-Maleyran S, Lamarque S, Lorrain S, Lassalle R, Droz-Perroteau C, Mismetti P, Moore N.

Pharmacol Res. 2019 Mar;141:201-207. doi: 10.1016/j.phrs.2018.12.018. Epub 2018 Dec 21.

PMID:
30583081
44.

Survivorship issues in older breast cancer survivors.

Coughlin SS, Paxton RJ, Moore N, Stewart JL, Anglin J.

Breast Cancer Res Treat. 2019 Feb;174(1):47-53. doi: 10.1007/s10549-018-05078-8. Epub 2018 Dec 1. Review.

PMID:
30506112
45.

Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial Fibrillation.

Blin P, Dureau-Pournin C, Cottin Y, Bénichou J, Mismetti P, Abouelfath A, Lassalle R, Droz C, Moore N.

Clin Pharmacol Ther. 2019 Jun;105(6):1439-1455. doi: 10.1002/cpt.1318. Epub 2019 Feb 6.

PMID:
30499605
46.

Using body mass index to estimate individualised patient radiation dose in abdominal computed tomography.

O'Neill S, Kavanagh RG, Carey BW, Moore N, Maher M, O'Connor OJ.

Eur Radiol Exp. 2018 Nov 28;2(1):38. doi: 10.1186/s41747-018-0070-5.

47.

Pharmacoepidemiology of non-steroidal anti-inflammatory drugs.

Moore N, Duong M, Gulmez SE, Blin P, Droz C.

Therapie. 2019 Apr;74(2):271-277. doi: 10.1016/j.therap.2018.11.002. Epub 2018 Nov 8.

PMID:
30477749
48.

Repeated elevated plus maze trials as a measure for tracking within-subjects behavioral performance in rats (Rattus norvegicus).

Schrader AJ, Taylor RM, Lowery-Gionta EG, Moore NLT.

PLoS One. 2018 Nov 26;13(11):e0207804. doi: 10.1371/journal.pone.0207804. eCollection 2018.

49.

Low-dose CT imaging of the acute abdomen using model-based iterative reconstruction: a prospective study.

Moloney F, James K, Twomey M, Ryan D, Grey TM, Downes A, Kavanagh RG, Moore N, Murphy MJ, Bye J, Carey BW, McSweeney SE, Deasy C, Andrews E, Shanahan F, Maher MM, O'Connor OJ.

Emerg Radiol. 2019 Apr;26(2):169-177. doi: 10.1007/s10140-018-1658-z. Epub 2018 Nov 17.

PMID:
30448900
50.

Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillation.

Blin P, Dureau-Pournin C, Cottin Y, Bénichou J, Mismetti P, Abouelfath A, Lassalle R, Droz C, Moore N.

Br J Clin Pharmacol. 2019 Feb;85(2):432-441. doi: 10.1111/bcp.13815. Epub 2018 Dec 16.

PMID:
30423205

Supplemental Content

Support Center